https://www.pharmaceutical-technology.com/data-insights/pimitespib-otsuka-pharmaceutical-small-cell-lung-cancer-likelihood-of-approval/
Pimitespib is under clinical development by Otsuka Pharmaceutical and currently in Phase I for Small-Cell Lung Cancer.
otsuka pharmaceuticalsmall celllung cancerpimitespiblikelihood